VEGF Antibody / Angiogenesis Growth Factor Antibody (R31500)

VEGF Antibody Human Cancer IHC. Immunohistochemical staining of FFPE human rectal cancer tissue using VEGF Antibody. HIER was performed by boiling tissue sections in pH 6 citrate buffer for 20 minutes prior to staining. An HRP-conjugated secondary antibody with DAB substrate was used for detection. VEGF Antibody, an Angiogenesis Growth Factor Antibody, demonstrates strong cytoplasmic staining in tumor cells, consistent with VEGF expression associated with tumor angiogenesis, vascular remodeling, and hypoxia-regulated cancer progression pathways.

VEGF Antibody Human Rectal Cancer IHC. Immunohistochemical staining of FFPE human rectal cancer tissue using VEGF Antibody. HIER was performed by boiling tissue sections in pH 6 citrate buffer for 20 minutes prior to staining. An HRP-conjugated secondary antibody with DAB substrate was used for detection. VEGF Antibody, an Angiogenesis Growth Factor Antibody, demonstrates cytoplasmic staining in tumor and stromal-associated cells, consistent with the role of VEGF in tumor angiogenesis, endothelial cell signaling, and vascular remodeling within the cancer microenvironment.

VEGF Antibody Rat Brain IHC. Immunohistochemical staining of FFPE rat brain tissue using VEGF Antibody. HIER was performed by boiling tissue sections in pH 6 citrate buffer for 20 minutes prior to staining. An HRP-conjugated secondary antibody with DAB substrate was used for detection. VEGF Antibody, an Angiogenesis Growth Factor Antibody, demonstrates cytoplasmic staining in neuronal and glial cell populations, consistent with the role of VEGF in vascular regulation, neurovascular signaling, and tissue remodeling processes within the central nervous system.

VEGF Antibody Human, Mouse and Rat WB. Western blot analysis of recombinant VEGF protein, human cell lysates, rat samples, and mouse samples using VEGF Antibody. Lane 1: 20 ng recombinant VEGF protein, Lane 2: 10 ng recombinant VEGF protein, Lane 3: human U-87 MG, Lane 4: human K562, Lane 5: human U-251, Lane 6: rat brain, Lane 7: rat C6, Lane 8: mouse brain, Lane 9: mouse Neuro-2a cell lysate. An HRP-conjugated secondary antibody with ECL substrate was used for detection. VEGF Antibody, an Angiogenesis Growth Factor Antibody, detects VEGF-A bands corresponding to the expected ~19-22 kDa monomer and ~38-44 kDa dimer forms, supporting analysis of VEGF expression in angiogenesis, vascular signaling, and tumor biology research.

VEGF Antibody Human Ovarian Cancer IHC. Immunohistochemical staining of FFPE human ovarian serous adenocarcinoma tissue using VEGF Antibody. HIER was performed by boiling tissue sections in pH 8 EDTA buffer for 20 minutes prior to staining. An HRP-conjugated secondary antibody with DAB substrate was used for detection. VEGF Antibody, an Angiogenesis Growth Factor Antibody, demonstrates cytoplasmic staining in tumor cells and stromal-associated regions, consistent with VEGF expression in tumor angiogenesis, vascular remodeling, and regulation of the cancer microenvironment.

VEGF Antibody Human Lung Cancer IHC. Immunohistochemical staining of FFPE human lung cancer tissue using VEGF Antibody. HIER was performed by boiling tissue sections in pH 8 EDTA buffer for 20 minutes prior to staining. An HRP-conjugated secondary antibody with DAB substrate was used for detection. VEGF Antibody, an Angiogenesis Growth Factor Antibody, demonstrates cytoplasmic staining in tumor cells and surrounding stromal regions, consistent with VEGF expression associated with tumor angiogenesis, endothelial cell signaling, and vascular remodeling within the tumor microenvironment.

VEGF Antibody Human Immune Cell FACS. Flow cytometric analysis of fixed human K562 cells using VEGF Antibody at 1 ug/million cells. Cells were blocked with goat serum and compared against cells alone (red) and isotype control (green). VEGF Antibody, an Angiogenesis Growth Factor Antibody, demonstrates a clear positive shift (blue), confirming VEGF expression in K562 cells and supporting its use for studying angiogenic signaling, hypoxia-regulated growth factor expression, and vascular biology pathways.